medigraphic.com
SPANISH

Salud Pública de México

Instituto Nacional de Salud Pública
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 4

<< Back

salud publica mex 2024; 66 (4)

Pandemic preparedness: required actions. Conclusions of the PUIREE 2024 multidisciplinary panel

Rodríguez-Álvarez M, Ponce de León-Rosales S, Zaidi-Jacobson M, Pérez-Cuevas R, Argüelles-Gómez C, Baridó-Murguía ME, Campillo-Balderas JA, Cornejo-Juárez P, Cruz-Hervert LP, Cruz-Pacheco G, de la Concha F, Díaz-Ramírez JB, García-García ML, Hernández-Cárdenas CM, Jácome-Ramírez R, Jiménez-Corona ME, Lazcano-Araujo A, Linares-Salgado JE, López-Vidal Y, Martínez-Cristo N, Martuscelli-Quintana J, Miranda-Novales MG, Ochoa-Hein E, Provencio-Durazo E, Santillán-Doherty P, Soto-Nieto GI, Torres-Ruiz MF, Volkow-Fernández P
Full text How to cite this article

Language: Spanish
References: 23
Page: 616-626
PDF size: 263.07 Kb.


Key words:

pandemic preparedness, pandemic, intersectoral collaboration, risk communication, prevention, health systems strengthening.

ABSTRACT

Objective. In response to the growing threat of pandemic risks and the recent experience of the Covid-19 pandemic, UNAM through the PUIREE carried out a multidisciplinary analysis to identify and prioritize essential actions for the response to pandemics in Mexico. Materials and methods. The structured Delphi method of communication and analysis was used, and a questionnaire was presented to the health and life experts. In three meetings, discussions were held about the actions that should contain a pandemic preparedness and response plan for Mexico. Results. Key areas of intervention were identified: the need for effective coordination between all levels of Government, health institutions and diverse sectors of the population; the importance of a transparent and effective communication system, as well as the strengthening of infrastructure and trained human resources for health care in public institutions. The need to invest in research and development to ensure self-sufficiency in the production of vaccines and medicines, as well as the implementation of early physical distancing and confinement measures, was also highlighted. Conclusions. Effective pandemic preparedness requires immediate actions to achieve comprehensive and multidisciplinary planning, as well as collaboration and communication between academies and related sectors to minimize the impact and threats of future pandemics. The above will strengthen Mexico’s response capacity and serve as a model for other low- and middle-income countries.


REFERENCES

  1. Oshitani H, Kamigaki T, Suzuki A. Major issues and challenges of influenzapandemic preparedness in developing countries. Emerg Infect Dis. 2008;14(6):875-80. https://doi.org/10.3201/eid1406.070839

  2. Fineberg HV. Pandemic preparedness and response-lessons from theH1N1 influenza of 2009. N Engl J Med. 2014;370(14):1335-42. https://doi.org/10.1056/NEJMra1208802

  3. Khan MS, Dar O, Erondu NA, Rahman-Shepherd A, Hollmann L,Ihekweazu C, et al. Using critical information to strengthen pandemicpreparedness: the role of national public health agencies. BMJ Glob Health.2020;5(9):e002830. https://doi.org/10.1136/bmjgh-2020-002830

  4. Worldometer. COVID-19 CORONAVIRUS PANDEMIC. Dover:Worldometers, 2024 [citado abr 1, 2024]. Disponible en: https://www.worldometers.info/coronavirus/

  5. Alimohamadi Y, Tola HH, Abbasi-Ghahramanloo A, Janani M, Sepandi M.Case fatality rate of COVID-19: a systematic review and meta-analysis. JPrev Med Hyg. 2021;62(2):E311-20. https://doi.org/10.15167/2421-4248/jpmh2021.62.2.1627

  6. Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematicreview and meta-analysis of 42 studies and 423,117 patients. BMCInfect Dis. 2021;21(1):855. https://doi.org/10.1186/s12879-021-06536-3

  7. Squalli J. Deciphering the link between healthcare expenditure, corruption,and COVID-19 mortality. Sci Rep. 2024;14(1):12702. https://doi.org/10.1038/s41598-024-63766-6

  8. Tawde P, Igburuke L, Olanipekun D, Marwaha V, Lambo J. Prognostic factorsfor mortality in adults hospitalized with COVID-19 infection in the Americas.Cureus. 2024;16(2):e55044. https://doi.org/10.7759/cureus.55044

  9. Savedoff W, Góngora P, Giedion U, Distrutti M. Gasto inteligente ensalud. Cómo hacer que cada peso cuente. Washington: Banco Interamericanode Desarrollo, 2023 [citado abr 1, 2024]. Disponible en: https://publications.iadb.org/en/publications/spanish/viewer/Gasto-inteligente-ensalud-como-hacer-que-cada-peso-cuente.pdf

  10. Organización Mundial de la Salud. Pandemic influenza preparednessand response: a WHO guidance document. Ginebra: OMS, 2009[citado abr 1, 2024]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK143062/pdf/Bookshelf_NBK143062.pdf

  11. Organización Mundial de la Salud. 2019 Novel Coronavirus (2019-nCoV) strategic preparedness and response plan. Ginebra: OMS, 2021[citado abr 1, 2024]. Disponible en: https://www.who.int/publications/i/item/strategic-preparedness-and-response-plan-for-the-new-coronavirus

  12. Organización Mundial de la Salud. Timeline: WHO’s COVID-19 response.Ginebra: OMS, 2024 [citado 1 abr, 2024]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline

  13. Centro Nacional de Programas Preventivos y Control de Enfermedades.Plan nacional para la preparación y respuesta ante la intensificación de lainfluenza estacional o ante una pandemia de influenza. Ciudad de México:SS, 2018 [citado may 1, 2024]. Disponible en: https://www.gob.mx/salud/cenaprece/documentos/plan-nacional-para-la-preparacion-y-respuesta-ante-laintensificacion-de-la-influenza-estacional-o-ante-una-pandemia-de-influenza

  14. Dirección General de Epidemiología. Datos abiertos dirección general deepidemiología. COVID-19. Ciudad de México: SS, 2023 [citado may 1, 2024].Disponible en: https://www.gob.mx/salud/documentos/datos-abiertos-152127

  15. Gobierno de México. Exceso de mortalidad en México. Ciudad deMéxico: Gobierno de México, 2023 [citado abr 1, 2024]. Disponible en:https://coronavirus.gob.mx/exceso-de-mortalidad-en-mexico/

  16. Rodríguez-Alvarez M, Ponce de León-Rosales S, Zaidi-Jacobson M,Pérez-Cuevas R, Arguelles-Gómez C, Baridó-Murguóa ME, et al. Anexo 1.Síntesis curricular de los co-autores del artículo Preparación pandémica:acciones requeridas [conclusiones del panel multidisciplinarioPUIREE – UNAM 2024]. México: Figshare, 2024. https://doi.org/10.6084/m9.figshare.26444986

  17. Neumann G, Kawaoka Y. Which virus will cause the next pandemic?Viruses. 2023;15(1):199. https://doi.org/10.3390/v15010199

  18. Chiu KHY, Sridhar S, Yuen KY. Preparation for the next pandemic:challenges in strengthening surveillance. Emerg Microbes Infect.2023;12(2):2240441. https://doi.org/10.1080/22221751.2023.2240441

  19. Organización Mundial de la Salud. Global research and innovationfor health emergencies. Building the world’s resilience againstfuture outbreaks and pandemics. Ginebra: OMS, 2023 [citado abr 1,

  20. 2024]. Disponible en: https://cdn.who.int/media/docs/default-source/documents/r-d-blueprint-meetings/global-research-and-innovation-forhealth-emergencies_report-2023.pdf20. Casadevall A. Pandemics past, present, and future: progress and persistentrisks. J Clin Invest. 2024;134(7):e179519. https://doi.org/10.1172/JCI179519

  21. Rodriguez-Álvarez M, López-Vidal Y, Soto-Hernandez JL, Miranda-Novales MG, Flores-Moreno K, Ponce de Leon-Rosales S. COVID-19:clouds over the antimicrobial resistance landscape. Arch Med Res.2021;52(1):123-6. https://doi.org/10.1016/j.arcmed.2020.10.010

  22. Petrakis V, Panopoulou M, Rafailidis P, Lemonakis N, Lazaridis G,Terzi I, et al. The Impact of the COVID-19 pandemic on antimicrobialresistance and management of bloodstream infections. Pathogens.2023;12(6):780. https://doi.org/10.3390/pathogens12060780

  23. Baquero F, Martínez JL, Lanza VF, Rodríguez-Beltrán J, Galán JC, SanMillán A, et al. Evolutionary pathways and trajectories in antibiotic resistance.Clin Microbiol Rev. 2021;34(4):e0005019. https://doi.org/10.1128/CMR.00050-19




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

salud publica mex. 2024;66